Polymerase chain reaction-based methods of DNA methylation analysis

被引:36
作者
Liu, ZJ [1 ]
Maekawa, M
机构
[1] Third Mil Med Univ, SW Hosp, Dept Lab Med, Chongqing 400038, Peoples R China
[2] Hamamatsu Univ Sch Med, Dept Lab Med, Hamamatsu, Shizuoka 4313192, Japan
关键词
D O I
10.1016/S0003-2697(03)00169-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
DNA methylation is the main epigenetic modification in humans, and changes in methylation patterns play an important role in tumorigenesis. Hypermethylation of normally unmethylated CpG islands in the promoter regions often occurs in important tumor suppressor genes, DNA repair genes, and metastasis inhibitor genes. The changes of methylation status of various gene promoters seem to be a common feature of malignant cells and these changes can occur early in the progression process. Therefore detection of aberrant promoter hypermethylation of cancer-related genes may be useful for cancer diagnosis or detection of cancer recurrence. The purpose of this review is to provide a summary of the most commonly used techniques for the study of DNA methylation. Current scientific literature involving methylation detection methods was reviewed with an emphasis on polymerase chain reaction (PCR)based detection methods. The current methodologies may be broadly classed into PCR-based methylation assays and non-PCR based methylation assays. The problems and advantages of the different methods for detecting aberrant methylation are discussed. As the number of genes known to be hypermethylated in cancer is growing, the detection of aberrant promoter region methylation will be a promising approach for using DNA-based markers for the early detection of human cancers. Many techniques, especially PCR-based methylation assay techniques, make it practical to use these new methylation biomarkers in early cancer diagnosis. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:259 / 265
页数:7
相关论文
共 40 条
[1]   Tumour class prediction and discovery by microarray-based DNA methylation analysis -: art. no. e21 [J].
Adorján, P ;
Distler, J ;
Lipscher, E ;
Model, F ;
Müller, J ;
Pelet, C ;
Braun, A ;
Florl, AR ;
Gütig, D ;
Grabs, G ;
Howe, A ;
Kursar, M ;
Lesche, R ;
Leu, E ;
Lewin, A ;
Maier, S ;
Müller, V ;
Otto, T ;
Scholz, C ;
Schulz, WA ;
Seifert, HH ;
Schwope, I ;
Ziebarth, H ;
Berlin, K ;
Piepenbrock, C ;
Olek, A .
NUCLEIC ACIDS RESEARCH, 2002, 30 (05) :e21
[2]  
Baylin SB, 1998, ADV CANCER RES, V72, P141
[3]   A novel technique for the identification of CpG islands exhibiting altered methylation patterns (ICEAMP) [J].
Brock, GJR ;
Huang, THM ;
Chen, CM ;
Johnson, KJ .
NUCLEIC ACIDS RESEARCH, 2001, 29 (24) :123
[4]   Simultaneous detection of CpG methylation and single nucleotide polymorphism by denaturing high performance liquid chromatography [J].
Deng, DJ ;
Deng, GR ;
Smith, MF ;
Zhou, J ;
Xin, HJ ;
Powell, SM ;
Lu, YY .
NUCLEIC ACIDS RESEARCH, 2002, 30 (03) :13
[5]   MethyLight: a high-throughput assay to measure DNA methylation [J].
Eads, Cindy A. ;
Danenberg, Kathleen D. ;
Kawakami, Kazuyuki ;
Saltz, Leonard B. ;
Blake, Corey ;
Shibata, Darryl ;
Danenberg, Peter V. ;
Laird, Peter W. .
NUCLEIC ACIDS RESEARCH, 2000, 28 (08) :32
[6]  
Esteller M, 1999, CANCER RES, V59, P67
[7]  
Esteller M, 1999, CANCER RES, V59, P793
[8]  
Esteller M, 1998, CANCER RES, V58, P4515
[9]   Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours [J].
Esteller, M ;
Herman, JG .
JOURNAL OF PATHOLOGY, 2002, 196 (01) :1-7
[10]  
Esteller M, 2001, CANCER RES, V61, P3225